Evaluation of the Safety and Efficacy of the Addition of AMD3100 to a G-CSF Mobilization Regimen in Patients With Lymphoma (NHL and HD) and Multiple Myeloma (MM).

Name: Evaluation of the Safety and Efficacy of the Addition of AMD3100 to a G-CSF Mobilization Regimen in Patients With Lymphoma (NHL and HD) and Multiple Myeloma (MM).
Published: 2007
License: Public Domain

Genzyme, a Sanofi Company · 2007

ClinicalTrials.gov · Datasets · License: Public Domain · 2007

Open Source ↗

lymphoma multiple-myeloma

lymphoma, non hodgkin's lymphoma, hodgkin's disease, multiple myeloma, mobilisation stem cells, g-csf mobilisation regimen, adult patients with lymphoma (non hodgkin's lymphoma, hodgkin's disease) or multiple myeloma who previously failed stem cell collections or collection attempts., interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Evaluation of the Safety and Efficacy of the Addition of AMD3100 to a G-CSF Mobilization Regimen in Patients With Lymphoma (NHL and HD) and Multiple Myeloma (MM).

Related documents